Evidence map›Paper›PMID 27481244›Full record

ArticleInfection and immunity2016

Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.

Afshin Zariri, Joep Beskers, Bas van de Waterbeemd, Hendrik Jan Hamstra, Tim H E Bindels, Elly van Riet, Jos P M van Putten, Peter van der Ley

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Co-opting the bacterial lipoprotein pathway for the biosynthesis of lipidated macrocyclic peptides.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Frontiers in microbiology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Afshin ZaririInstitute for Translational Vaccinology, Bilthoven, the Netherlands Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, the Netherlands Afshin.zariri@intravacc.nl.
Joep BeskersImmunology of Infectious Diseases and Vaccines, National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
Bas van de WaterbeemdInstitute for Translational Vaccinology, Bilthoven, the Netherlands.
Hendrik Jan HamstraImmunology of Infectious Diseases and Vaccines, National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
Tim H E BindelsInstitute for Translational Vaccinology, Bilthoven, the Netherlands.
Elly van RietInstitute for Translational Vaccinology, Bilthoven, the Netherlands.
Jos P M van PuttenDepartment of Infectious Diseases and Immunology, Utrecht University, Utrecht, the Netherlands.
Peter van der LeyInstitute for Translational Vaccinology, Bilthoven, the Netherlands.
Intravacc (Netherlands) · NLNational Institute for Public Health and the Environment · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningococcal outer membrane vesicles (OMVs) have been extensively investigated and successfully implemented as vaccines. They contain pathogen-associated molecular patterns, including lipopolysaccharide (LPS), capable of triggering innate immunity. However, Neisseria meningitidis contains an extremely potent hexa-acylated LPS, leading to adverse effects when its OMVs are applied as vaccines. To create safe OMV vaccines, detergent treatment is generally used to reduce the LPS content. While effective, this method also leads to loss of protective antigens such as lipoproteins. Alternatively, genetic modification of LPS can reduce its toxicity. In the present study, we have compared the effects of standard OMV isolation methods using detergent or EDTA with those of genetic modifications of LPS to yield a penta-acylated lipid A (lpxL1 and pagL) on the in vitro induction of innate immune responses. The use of detergent decreased both Toll-like receptor 4 (TLR4) and TLR2 activation by OMVs, while the LPS modifications reduced only TLR4 activation. Mutational removal of PorB or lipoprotein factor H binding protein (fHbp), two proteins known to trigger TLR2 signaling, had no effect, indicating that multiple TLR2 ligands are removed by detergent treatment. Detergent-treated OMVs and lpxL1 OMVs showed similar reductions of cytokine profiles in the human monocytic cell line MM6 and human dendritic cells (DCs). OMVs with the alternative penta-acylated LPS structure obtained after PagL-mediated deacylation showed reduced induction of proinflammatory cytokines interleukin-6 (IL-6) and IL-1β but not of IP-10, a typical TRIF-dependent chemokine. Taken together, these data show that lipid A modification can be used to obtain OMVs with reduced activation of innate immunity, similar to what is found after detergent treatment.

Indexed as

Bacterial Outer Membrane ProteinsCytokinesDendritic CellsDetergentsEdetic AcidHumansImmunity, InnateLipid AMeningococcal InfectionsMonocytesNeisseria meningitidisToll-Like ReceptorsBacterial Outer Membrane ProteinsCytokinesDetergentsEdetic AcidLipid AToll-Like Receptors

Identifiers

PMID27481244
PMCPMC5038073
OpenAlexW2484809182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.